Farallon Capital Management’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.9M | Buy |
9,157,000
+4,546,070
| +99% | +$23.3M | 0.2% | 51 |
|
|
2025
Q1 | $6.32M | Buy |
4,610,930
+610,930
| +15% | +$837K | 0.03% | 73 |
|
|
2024
Q4 | $12.4M | Buy |
+4,000,000
| New | +$12.4M | 0.06% | 71 |
|
|
2023
Q1 | – | Sell |
-270,000
| Closed | -$1.96M | – | 203 |
|
|
2022
Q4 | $1.96M | Sell |
270,000
-30,000
| -10% | -$218K | 0.01% | 166 |
|
|
2022
Q3 | $1.09M | Hold |
300,000
| – | – | 0.01% | 212 |
|
|
2022
Q2 | $1.36M | Hold |
300,000
| – | – | 0.01% | 211 |
|
|
2022
Q1 | $2.27M | Hold |
300,000
| – | – | 0.01% | 210 |
|
|
2021
Q4 | $3.28M | Hold |
300,000
| – | – | 0.02% | 197 |
|
|
2021
Q3 | $3.88M | Hold |
300,000
| – | – | 0.02% | 198 |
|
|
2021
Q2 | $3.41M | Buy |
+300,000
| New | +$3.41M | 0.01% | 195 |
|